Layer, Chiang, et al. Genome Biology
Pathogenica Bets on Next-Gen Sequencing for Fast, Multiplexed Pathogen Detection
The company, which is still exploring various next-gen sequencing platforms, plans to deploy its assay panels next year in a CLIA-certified lab setting and start testing them in clinical trials. It wants to launch an FDA-approved product by the end of 2012.
New to GenomeWeb? Register here quickly.